Preview

Meditsinskiy sovet = Medical Council

Advanced search

Effects of sertraline on cognitive function in patients with unipolar depressive disorders

https://doi.org/10.21518/2079-701X-2018-18-24-29

Abstract

Cognitive disfunction in depressive disorders have become a relevant aim of research in recent years. At the same time, the question of the influence of psychopharmacological drugs on the cognitive functioning of patients with depression also retains its significance. The article presents the results of a prospective study of the effect of sertraline on cognitive functions in patients with nonpsychotic unipolar depressive disorders. The study included 36 patients who received sertraline monotherapy for at least 12 weeks. The dynamics of depressive symptoms was assessed by the MADRS and HAM-D scales. The study of cognitive functions included memory testing (memory for faces), attention (Landolt rings), reaction time (sensorimotor reaction), psychomotor (tapping test) and executive functions (Stroop test, stress test, reaction to a moving object) with the help of the computer psychodiagnostic complex «Multipsychometer-05». The cognitive profile of the studied patients was characterized mainly by deficit of executive and psychomotor functions. The index of psychomotor activity significantly correlated with the severity of depressive symptoms. The use of sertraline contributed significantly to the reduction of depressive symptoms, as well as to the improvement of almost all the studied parameters of the cognitive profile, including memory, attention, reaction rate, psychomotor and performance functions.

About the Authors

R. V. Akhapkin
Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of the Ministry of Health of Russia
Russian Federation

Moscow



A. I. Fedorova
Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of the Ministry of Health of Russia
Russian Federation

Moscow



A. Z. Faizulloev
Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of the Ministry of Health of Russia
Russian Federation

Moscow



K. E. Emelin
Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of the Ministry of Health of Russia
Russian Federation

Moscow



References

1. Smulevich AB. Depression in patients with somatic and mental diseases. M: MIA, 2003, 432 p.

2. Krasnov VN, et al. The relationship between cognitive and emotional disorders in depression (literature review). Doctor.ru, 2013, 5 (83): 1–6

3. McIntyre R.S. et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety, 2013, 30(6): 515-527.

4. Shmukler AB. Cognitive impairment in the depressive syndrome pattern. Sotsialnaya i Klinicheskaya Psikhiatria, 2016, 26 (1): 72-76.

5. Porter R.J., Bourke C., Gallagher P. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Australian and New Zealand Journal of Psychiatry, 2007, 41(2): 115-128.

6. Buist‐Bouwman M.A. et al. Mediators of the association between depression and role functioning. Acta Psychiatr Scand, 2008, 118(6): 451-458.

7. Greer T.L., Kurian B.T., Trivedi M.H. Defining and measuring functional recovery from depression. CNS Drugs, 2010, 24: 267-284.

8. Ferguson J.M., Wesnes K.A., Schwartz G.E. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol, 2003, 8(1): 9-14.

9. Constant E.L. et al. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression. Depress Anxiety, 2005, 21(2): 78-89.

10. Herrera-Guzman I., Gudayol-Ferre E., HerreraAbarca J.E., Herrera-Guzman D., MontelongoPedraza P., Padros Blazquez F. et al. Major De pressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. J Affect Disord, 2010, 123: 341-350.

11. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry, 1979, 134: 382-389.

12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry, 1960, 23: 56-62.

13. Multipsychometer-05 hardware and software psychodiagnostic complex. Methodical manual, part 1, 2007

14. Gualtieri C.T., Johnson L.G., Benedict K.B. Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci, 2006, 18(2): 217-225.


Review

For citations:


Akhapkin RV, Fedorova AI, Faizulloev AZ, Emelin KE. Effects of sertraline on cognitive function in patients with unipolar depressive disorders. Meditsinskiy sovet = Medical Council. 2018;(18):24-29. (In Russ.) https://doi.org/10.21518/2079-701X-2018-18-24-29

Views: 4897


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)